Skip to main content
Log in

Fortgeschrittenes Melanom

Kombination aus Nivolumab und Ipilimumab auch bei Hirnmetastasen hoch effektiv!

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Tawbi HA et al. N Engl J Med. 2018;379(8):722–30

    Article  CAS  Google Scholar 

  2. Long GV et al. Lancet Oncol. 2018 May;19(5):672–81

    Article  CAS  Google Scholar 

  3. Margolin K et al. Lancet Oncol. 2012;13(5):459–65

    Article  CAS  Google Scholar 

  4. Long GV et al. Ann Oncol. 2017;28(7):1631–9

    Article  CAS  Google Scholar 

  5. Davies MA et al. Lancet Oncol. 2017;18(7):863–73

    Article  CAS  Google Scholar 

  6. Ascierto PA et al. Lancet Oncol. 2016;17(9):1248–60

    Article  CAS  Google Scholar 

  7. Dummer R et al. Lancet Oncol. 2018;19(5):603–15

    Article  CAS  Google Scholar 

Literatur

  • Tawbi HA et al. Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain. N Engl J Med. 2018; 379(8):722–30.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas Schalhorn.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schalhorn, A. Kombination aus Nivolumab und Ipilimumab auch bei Hirnmetastasen hoch effektiv!. Info Onkol. 21, 22–23 (2018). https://doi.org/10.1007/s15004-018-6270-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-018-6270-6

Navigation